Muhammad Ansab, Shree Rath, Amar Lal. "Afatinib versus chemotherapy in advanced NSCLC with uncommon
                    <i>EGFR</i>
                    mutations: A pooled individual patient–level survival analysis of ACHILLES/TORG1834 and LUX-Lung 2/3/6.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20736